Phenomenex has introduced 2.6µm and 1.7µm EVO C18 particle sizes, expanding its Kinetex core-shell column family.
The Kinetex EVO C18 columns provide a unique C18 selectivity, offering excellent peak shape for bases, 100% aqueous stability and rugged pH stability from one to 12 by incorporating a patented organo-silica grafting process that utilises uniform stabilising ethane cross-linking.
Designed to deliver the performance advantages of Core-Shell Technology at low, neutral and high pH ranges, Kinetex EVO C18 is suitable for any lab’s current reversed phase column portfolio.
The new, smaller particle sizes extend the versatility and scalability of this media, which was introduced initially in 5µm particles for HPLC and preparative HPLC work.
The columns are suitable for virtually every industry that relies on chromatography, including pharmaceutical drug discovery and development, clinical research, forensic toxicology, food safety and quality and environmental analysis.
The rugged EVO C18 columns are an extension of the Phenomenex Kinetex core-shell line. The 2.6µm EVO C18 columns offer performance comparable to sub-2µm fully porous particles on both standard LC and UHPLC systems, but at lower backpressures.
The 1.7µm particle size is designed for use with UHPLC systems and delivers on average 20% greater efficiencies than fully porous media. Both of the new particle sizes are directly scalable to each other and to the existing 5µm size.
“Customers have been very enthusiastic about the availability of core-shell performance at virtually any pH range,” said Simon Lomas, strategic marketing manager for Phenomenex.
“With these two new particle sizes, researchers can now achieve massive performance gains on their UHPLC and HPLC instruments while being able to take full advantage of high, low and medium pH conditions (pH 1-12) to influence selectivity.”
Phenomenex is a global technology leader committed to developing novel analytical chemistry solut...Learn More